NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 08/07/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,675.87 mln
Float125 mln
Earnings Date11/05/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.55
Likely reliable
1-Year Forecast
24.00
Fairly priced
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
2.87
Very high leverage
ROE
-33.18
Deeply negative
Business Description
Adaptive Biotechnologies, founded in 2009 and based in Seattle, Washington, uses advanced immune system analysis to help diagnose and treat a range of diseases. The company's core platform reads and interprets data from the immune system using proprietary biology and machine learning tools. Its flagship product, the clonoSEQ test, helps doctors detect and track tiny amounts of remaining cancer cells in patients during and after treatment. The company serves researchers, clinicians, and drug developers across the healthcare industry.
